España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Canaccord Genuity Gr
CCORF
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.88
0.16
2.37%
Pre-Market: Jul 31, 5:29 PM EDT
Get Report
Comment
Canaccord Genuity Gr (CCORF) Forecast
News
Earnings
Canaccord Genuity Gr (CCORF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Canaccord Genuity Gr (OTC:CCORF) Stock
Canaccord Genuity Gr Stock (OTC: CCORF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, August 26, 2024
Leading US Cannabis Operator Gets Buy Rating Amid Strategic Divestment And Growth Initiative
Patricio Liddle
Thursday, April 11, 2024
Drill Bit Hits 25 G/T Gold at South Dakota Project
The Gold Report
Friday, April 05, 2024
Is Estée Lauder on the Verge Of a Massive Comeback?
MarketBeat
Tuesday, March 26, 2024
Apple Faces DOJ Scrutiny, but Not These 3 Under the Radar Names
MarketBeat
Tuesday, February 06, 2024
Fission Uranium Announces Funding For Uranium Project In Saskatchewan
Stjepan Kalinic
Tuesday, June 20, 2023
TD Securities Maintains Buy on Canaccord Genu...
Benzinga Newsdesk
Wednesday, March 15, 2023
Save Your Struggling Cannabis Business: Canaccord Genuity's Managing Director Has Some Valuable Advice
Joana Scopel
Friday, October 28, 2022
Agrify Secures $15M Via Its At-The-Market Equity Program
Vuk Zdinjak
Thursday, September 01, 2022
This Company Is Poised To Become The Heartbeat Of The World's 6th Most Attractive Mining Jurisdiction
Ernest Dela Aglanu
-
Sponsored
Friday, May 27, 2022
Aurora Cannabis Upsizes Bought Deal Financing
Vuk Zdinjak
Monday, May 16, 2022
Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details
Vuk Zdinjak
Tuesday, May 03, 2022
HEXO Launches New At-the-Market Offering, Here Are The Details
Vuk Zdinjak
Wednesday, November 03, 2021
Cannabis Co. Kiaro Closes $3.75M Brokered Private Placement
Javier Hasse
Monday, August 16, 2021
Cannabis Unicorn PharmaCann Could IPO Soon, Valued At $1.1B+
Javier Hasse
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Thursday, November 21, 2019
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Tuesday, November 19, 2019
Stocks That Hit 52-Week Lows On Tuesday
Lisa Levin
Thursday, February 21, 2019
A Chat With The CEO Behind The Cannabis Company With The 'BOSS' Ticker: 'There Isn't A Single Route To Success'
Javier Hasse
Sunday, February 03, 2019
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
Javier Hasse
Wednesday, July 05, 2017
Canaccord Genuity Acquires Hargreave Hale for...
Benzinga
Thursday, April 02, 2015
Canaccord CEO Paul Reynolds Dies After Becomi...
Benzinga
Monday, February 02, 2015
Canaccord Genuity Announces 4% Workforce Redu...
Benzinga
Wednesday, May 23, 2012
Canaccord Financial Posts FQ4 Net Loss
Benzinga
